Is InfuSystem Holdings, Inc. overvalued or undervalued?

As of 31 October 2025, the valuation grade for InfuSystem Holdings, Inc. moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently overvalued, as suggested by its P/E ratio of 47, which is notably higher than the industry average, and an EV to EBITDA ratio of 8.31, also on the higher side. Additionally, the PEG ratio stands at an extremely low 0.01, further highlighting the disconnect between price and growth expectations.
In comparison to its peers, InfuSystem's P/E ratio of 47 is lower than Lincoln Educational Services Corp.'s 59.63 but significantly higher than TaskUs, Inc.'s 27.32, which is classified as very attractive. The company's recent stock performance shows a 67.37% return over the past year, outperforming the S&P 500's 19.89% return, but its long-term performance has been poor, with a -15.91% return over the past five years compared to the S&P 500's 109.18%. This mixed performance underscores the current overvaluation of the stock.